AChE/BChE/BACE-1-IN-1

Modify Date: 2024-01-09 20:31:00

AChE/BChE/BACE-1-IN-1 Structure
AChE/BChE/BACE-1-IN-1 structure
Common Name AChE/BChE/BACE-1-IN-1
CAS Number 1321361-13-0 Molecular Weight 350.38
Density N/A Boiling Point N/A
Molecular Formula C19H21F3N2O Melting Point N/A
MSDS N/A Flash Point N/A

 Use of AChE/BChE/BACE-1-IN-1


AChE/BChE/BACE-1-IN-1 (Compound 4k) is an orally active inhibitor of AChE, BChE, and BACE-1 with IC50 values of 0.058, 0.082 and 0.115 μM against hAChE, hBChE and hBACE-1, respectively. AChE/BChE/BACE-1-IN-1 shows considerable PAS-AChE binding capability, excellent brain permeation, potential disassembly of Aβ aggregates, and neuroprotective activity against Aβ-induced stress. AChE/BChE/BACE-1-IN-1 has remarkable antioxidant potential[1].

 Names

Name AChE/BChE/BACE-1-IN-1

 AChE/BChE/BACE-1-IN-1 Biological Activity

Description AChE/BChE/BACE-1-IN-1 (Compound 4k) is an orally active inhibitor of AChE, BChE, and BACE-1 with IC50 values of 0.058, 0.082 and 0.115 μM against hAChE, hBChE and hBACE-1, respectively. AChE/BChE/BACE-1-IN-1 shows considerable PAS-AChE binding capability, excellent brain permeation, potential disassembly of Aβ aggregates, and neuroprotective activity against Aβ-induced stress. AChE/BChE/BACE-1-IN-1 has remarkable antioxidant potential[1].
Related Catalog
Target

IC50: 0.058 μM (hAChE), 0.082 μM (hBChE), 0.115 μM (hBACE-1)[1]

In Vivo AChE/BChE/BACE-1-IN-1 (Compound 4k) (0-10 mg/kg; p.o.) ameliorates cognitive dysfunction against the scopolamine-induced amnesia model in the Y-maze test[1].
References

[1]. Choubey PK, et al. Design, synthesis, and multitargeted profiling of N-benzylpyrrolidine derivatives for the treatment of Alzheimer's disease. Bioorg Med Chem. 2020 Nov 15;28(22):115721.

 Chemical & Physical Properties

Molecular Formula C19H21F3N2O
Molecular Weight 350.38
The content on this webpage is sourced from various professional data sources. If you have any questions or concerns regarding the content, please feel free to contact service1@chemsrc.com.